SANTEN PHARMACEUTICAL CO.,LTD. Logo

SANTEN PHARMACEUTICAL CO.,LTD.

A global company specializing in pharmaceuticals and medical devices for ophthalmology.

4536 | T

Overview

Corporate Details

ISIN(s):
JP3336000009
LEI:
Country:
Japan
Address:
大阪市北区大深町4番20号

Description

Santen Pharmaceutical Co., Ltd. is a global company specializing in ophthalmology. It is engaged in the research, development, manufacturing, sales, and marketing of pharmaceutical products and medical devices dedicated to eye health. The company's portfolio includes prescription and over-the-counter pharmaceuticals that address a wide range of ophthalmic conditions. Serving patients, consumers, and medical professionals in over 60 countries, Santen aims to contribute to the realization of “Happiness with Vision” by providing valuable products and services worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-15 06:37
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 24.5 KB
2025-11-14 01:56
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.9 KB
2025-11-10 07:02
確認書
Japanese ZIP 8.7 KB
2025-11-10 07:01
半期報告書-第114期(2025/04/01-2026/03/31)
Japanese ZIP 366.6 KB
2025-10-15 03:28
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 24.2 KB
2025-09-12 04:58
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.9 KB
2025-08-13 03:24
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.8 KB
2025-07-15 04:38
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 25.2 KB
2025-06-25 04:08
臨時報告書
Japanese ZIP 26.5 KB
2025-06-24 09:22
臨時報告書
Japanese ZIP 32.1 KB
2025-06-23 08:29
内部統制報告書-第113期(2024/04/01-2025/03/31)
Japanese ZIP 24.3 KB
2025-06-23 08:28
確認書
Japanese ZIP 8.5 KB
2025-06-23 08:27
有価証券報告書-第113期(2024/04/01-2025/03/31)
Japanese ZIP 2.2 MB
2025-06-13 04:35
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 22.1 KB
2025-04-15 06:53
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese ZIP 21.3 KB

Automate Your Workflow. Get a real-time feed of all SANTEN PHARMACEUTICAL CO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SANTEN PHARMACEUTICAL CO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SANTEN PHARMACEUTICAL CO.,LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Aldeyra Therapeutics, Inc. Logo
Develops medications for immune-mediated ocular and systemic diseases.
United States of America
ALDX
Alector, Inc. Logo
Clinical-stage biotech using immuno-neurology to treat neurodegenerative diseases.
United States of America
ALEC
ALK-Abelló Logo
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
Denmark
ALK
Alkaloid AD Logo
Manufactures generic pharmaceuticals, cosmetics, and chemical products.
North Macedonia
ALK
Alkermes plc. Logo
Develops and commercializes medicines for central nervous system (CNS) diseases.
United States of America
ALKS
Allarity Therapeutics, Inc. Logo
A clinical-stage biopharma using diagnostics to develop targeted cancer therapies.
United States of America
ALLR
ALLERGY THERAPEUTICS PLC Logo
Immunology company developing aluminum-free vaccines and therapies for allergies.
United Kingdom
AGY
Alligator Bioscience Logo
Clinical-stage biotech developing tumor-directed immuno-oncology antibody drugs.
Sweden
ATORX
Allogene Therapeutics, Inc. Logo
Develops off-the-shelf allogeneic CAR T therapies for cancer and autoimmune diseases.
United States of America
ALLO
Almirall S.A. Logo
Global biopharmaceutical company specializing in medical dermatology and skin health.
Spain
ALM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.